BIOMAT Database Logo BIOMAT Database Logo

Artificially depleted plasma for factor VIIIC assays. 1985

G S Gabra, and M Thompson, and R Mitchell

UI MeSH Term Description Entries
D007202 Indicators and Reagents Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499) Indicator,Reagent,Reagents,Indicators,Reagents and Indicators
D010949 Plasma The residual portion of BLOOD that is left after removal of BLOOD CELLS by CENTRIFUGATION without prior BLOOD COAGULATION. Blood Plasma,Fresh Frozen Plasma,Blood Plasmas,Fresh Frozen Plasmas,Frozen Plasma, Fresh,Frozen Plasmas, Fresh,Plasma, Blood,Plasma, Fresh Frozen,Plasmas,Plasmas, Blood,Plasmas, Fresh Frozen
D005169 Factor VIII Factor VIII of blood coagulation. Antihemophilic factor that is part of the factor VIII/von Willebrand factor complex. Factor VIII is produced in the liver and acts in the intrinsic pathway of blood coagulation. It serves as a cofactor in factor X activation and this action is markedly enhanced by small amounts of thrombin. Coagulation Factor VIII,Factor VIII Clotting Antigen,Factor VIII Coagulant Antigen,Factor VIII Procoagulant Activity,Thromboplastinogen,Blood Coagulation Factor VIII,F VIII-C,Factor 8,Factor 8 C,Factor Eight,Factor VIIIC,Hyate-C,Hyatt-C,F VIII C,Hyate C,HyateC,Hyatt C,HyattC
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

G S Gabra, and M Thompson, and R Mitchell
Artificially depleted plasma for manufacturers international calibration of thromboplastin.
January 1986, Clinical and laboratory haematology,
G S Gabra, and M Thompson, and R Mitchell
Disparity between one- and two-stage factor VIII assays in measuring VIIIC in heparinized plasma.
December 1985, Thrombosis and haemostasis,
G S Gabra, and M Thompson, and R Mitchell
Acquired factor VIIIC deficiency due to circulating factor VIIIC inhibitors.
October 1988, Annals of the Academy of Medicine, Singapore,
G S Gabra, and M Thompson, and R Mitchell
Assay of plasma thromboplastin antecedent (PTA) with artificially depleted normal plasma.
July 1963, Blood,
G S Gabra, and M Thompson, and R Mitchell
High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism.
January 2000, Thrombosis and haemostasis,
G S Gabra, and M Thompson, and R Mitchell
Plasma exchange in non-haemophiliac patients with inhibitors to factor VIIIC.
September 1981, British medical journal (Clinical research ed.),
G S Gabra, and M Thompson, and R Mitchell
Plasmapheresis and Factor VIIIC inhibitors.
February 1985, Lancet (London, England),
G S Gabra, and M Thompson, and R Mitchell
Amidolytic end-point methods for factor VIIIC inhibitors.
October 1982, Medical laboratory sciences,
G S Gabra, and M Thompson, and R Mitchell
[Acquired autoantibodies directed against human factor VIIIc. Treatment of 2 hemorrhagic accidents with porcine factor VIIIc].
March 1993, Presse medicale (Paris, France : 1983),
G S Gabra, and M Thompson, and R Mitchell
Viral safety and inhibitor development associated with factor VIIIC ultra-purified from plasma in hemophiliacs previously unexposed to factor VIIIC concentrates. The Monoclate Study Group.
April 1990, Seminars in hematology,
Copied contents to your clipboard!